Biogen Other Current Borrowings (Quarterly) Analysis

Biogen, Inc. (BIIB)

164.71 +0.29 (+0.18%) USD | NASDAQ | Jan 20, 11:38

View Other Current Borrowings (Quarterly) for BIIB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Borrowings (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Borrowings (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Borrowings (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
AbbVie, Inc.	--
Stoke Therapeutics, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Insmed, Inc.	--